Free Trial

Qualigen Therapeutics (QLGN) Insider Trading & Ownership

Qualigen Therapeutics logo
$3.90 -0.14 (-3.47%)
(As of 12/20/2024 05:16 PM ET)

Qualigen Therapeutics (NASDAQ:QLGN) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
1.80%
Number Of
Insiders Buying
(Last 3 Years)
2
Amount Of
Insider Buying
(Last 3 Years)
$35,700.00
Number Of
Insiders Selling
(Last 3 Years)
0
Get QLGN Insider Trade Alerts

Want to know when executives and insiders are buying or selling Qualigen Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

QLGN Insider Buying and Selling by Quarter

Qualigen Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/22/2022Michael S PoirierCEOBuy600$28.50$17,100.00  
6/14/2022Amy S BroidrickInsiderBuy600$31.00$18,600.00  
(Data available from 1/1/2013 forward)

QLGN Insider Trading Activity - Frequently Asked Questions

The list of insiders at Qualigen Therapeutics includes Amy S Broidrick, and Michael S Poirier. Learn more on insiders at QLGN.

1.80% of Qualigen Therapeutics stock is owned by insiders. Learn more on QLGN's insider holdings.

Qualigen Therapeutics Key Executives



This page (NASDAQ:QLGN) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners